T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
Chatenoud
L
L
INSERM U25, Hôpital Necker, Paris, France.
Bach
J F
JF
D000818:Animals; D000910:Antibodies, Heterophile / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D000918:Antibody Specificity / Q000276:immunology; D001327:Autoimmune Diseases / Q000628:therapy*; D000939:Epitopes / Q000276:immunology; D006801:Humans; D007114:Immunization; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*
D000910:Antibodies, Heterophile; D000911:Antibodies, Monoclonal; D000939:Epitopes; D011948:Receptors, Antigen, T-Cell